Inhaled Mucoactive Drugs for Treating Non-Cystic Fibrosis Bronchiectasis in Children
Open Access
- 1 April 2013
- journal article
- letter
- Published by SAGE Publications in International Journal of Immunopathology and Pharmacology
- Vol. 26 (2) , 529-534
Abstract
Non-cystic fibrosis bronchiectasis (nCFb) is an acquired condition of variable etiology. Medical treatment basically involves antibiotics and chest physiotherapy. An impaired mucociliary clearance seems to be one of the mechanisms behind nCFb, and inhaled therapy with mucoactive agents has frequently been used to try to correct it. The most often used mucoactive agents in this setting are N-acetylcysteine, hypertonic saline solution (HS), mannitol powder and recombinant human DNase (rhDNase). Reviewing the international medical literature on the use of these drugs for patients with nCFb from 1992 to the present day, we retrieved 88 articles, only 12 of which met our selection criteria for this analysis. We found only 2 papers and 2 reviews on the use of rhDNase in children, and in adults 3 trials on HS, 5 on mannitol powder and 2 on rhDNase. In conclusion, no observational or randomized controlled trials (RCT) have been published on the use of these drugs in children with nCFb, while the few conducted on adult patients report some evidence of their effects. Further studies are needed on inhaled mucoactive drugs for the treatment of children with nCFb.Keywords
This publication has 20 references indexed in Scilit:
- The long term effect of inhaled hypertonic saline 6% in non-cystic fibrosis bronchiectasisRespiratory Medicine, 2012
- Nebulised 7% hypertonic saline improves lung function and quality of life in bronchiectasisRespiratory Medicine, 2011
- Differences and similarities in non-cystic fibrosis bronchiectasis between developing and affluent countriesPaediatric Respiratory Reviews, 2011
- Effect of mannitol and repetitive coughing on the sputum properties in bronchiectasisRespiratory Medicine, 2010
- Pharmacological Treatment Options for BronchiectasisDrugs, 2009
- Effect of increasing doses of mannitol on mucus clearance in patients with bronchiectasisEuropean Respiratory Journal, 2007
- Evaluation of nebulised hypertonic saline (7%) as an adjunct to physiotherapy in patients with stable bronchiectasisRespiratory Medicine, 2005
- Inhaled mannitol for the treatment of mucociliary dysfunction in patients with bronchiectasis: Effect on lung function, health status and sputumRespirology, 2005
- The 24-h Effect of Mannitol on the Clearance of Mucus in Patients With BronchiectasisChest, 2001
- Inhalation of Dry Powder Mannitol Improves Clearance of Mucus in Patients with BronchiectasisAmerican Journal of Respiratory and Critical Care Medicine, 1999